21st Austria weekly - Kontron, Vienna Airport Group (15/07/2025)

Kontron: Global IoT technology company Kontron announced the conclusion of a service contract with SNCF France (Société Nationale des Chemins de fer Français) worth a three-digit million euro amount. The contract is the logical continuation of the long-term partnership between Kontron Transportation and SNCF. With this significant contract, Kontron Transportation emphasizes its strong capability to build mission-critical communication systems that meet current customer needs, positioning itself as a reliable and long-term trusted partner in the technology transition from GSM-R (Global System for Mobile Communication – Railway) to Future Railway Mobile Communication System (FRMCS).
Kontron: weekly performance: 10.33%

Vienna Airport Group: Total passenger volume in the entire Flughafen Wien Group (Vienna Airport, Malta Airport and Kosice Airport) in June rose 1.5% year-on-year to 4,031,270 travellers. Due to the conflict situation between Iran and Israel, passenger traffic at Vienna Airport was down slightly to 3,008,513 travellers (-0.4%). Passenger volume in the entire Flughafen Wien Group (Vienna Airport, Malta Airport and Kosice Airport) in the first six-month of 2025 was up 4.7% to 19,598,242 travellers.
VIG: weekly performance: 1.83%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (15/07/2025)

Christian Drastil: Wiener Börse Plausch

Börsepeople im Podcast S23/03: Barbara Riedl-Wiesinger

Bildnachweis

1. wikifolio-View 19.11.: Gekauft wurde Deutsche Bank, verkauft Kontron   >> Öffnen auf photaq.com

Aktien auf dem Radar:Amag, Polytec Group, DO&CO, Semperit, Rosenbauer, UBM, Rosgix, AT&S, Bawag, Verbund, Uniqa, RBI, voestalpine, Austriacard Holdings AG, Rath AG, SBO, Addiko Bank, Frequentis, BKS Bank Stamm, Oberbank AG Stamm, RHI Magnesita, Mayr-Melnhof, Telekom Austria, Österreichische Post, Siemens Energy, Fresenius Medical Care, E.ON , RWE, SAP, Scout24, BASF.

Random Partner

---

Marinomed
Marinomed hat die Vision, das Leben von Patienten, die an Krankheiten mit unzureichenden Behandlungsmöglichkeiten leiden, in zwei wichtigen therapeutischen Bereichen nachhaltig zu verbessern: Virologie und Immunologie.

>> Besuchen Sie 61 weitere Partner auf boerse-social.com/partner